AUG 14, 2026 · PHASE 3 TRIAL
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
ClinicalTrials.gov
This is a registered but actively recruiting Phase 3 trial with no reported results; the registry record describes planned design and endpoints only, not outcomes.
Reported
Planned enrollment250
Study duration52 weeks
Primary endpointChange in Apnea-hypopnea Index (AHI) from b…